• Image of Xopenex HFA medication Image of Xopenex HFA medication
    • LEVALBUTEROL TARTRATE HFA (Generic for XOPENEX HFA)

LEVALBUTEROL (lev al BYOO ter ol) treats lung diseases, such as asthma, where the airways in the lungs narrow, causing breathing problems or wheezing (bronchospasm). It works by opening the airways of the lungs, making it easier to breathe. It is often called a rescue or quick-relief inhaler.


LEVALBUTEROL TARTRATE HFA (Generic for XOPENEX HFA) Lifestyle Interactions

  • Eltrombopag Olamine 50mg, Oral tablet

    Interaction: food high in calcium
    Severity: Major
    Notes for Consumers: Take Eltrombopag 1 hour before or 4 hours after you have food. Foods high in calcium may decrease the amount of Eltrombopag absorbed by the stomach, which can decrease the effects of Eltrombopag.
    Notes for Professionals: Eltrombopag chelates polyvalent cations (e.g., calcium, aluminum, and magnesium) in food. Systemic exposure to eltrombopag may be decreased when it is coadministered with a polyvalent cation-containing product. Eltrombopag should not be taken within 4 hours of any oral products containing polyvalent cations, such as calcium salts.
  • Eltrombopag Olamine 50mg, Oral tablet

    Interaction: Foods High in Iron
    Severity: Major
    Notes for Consumers: Take Eltrombopag 1 hour before or 4 hours after you have food. Foods high in iron may decrease the amount of Eltrombopag absorbed by the stomach, which can decrease the effects of Eltrombopag.
    Notes for Professionals: Eltrombopag chelates polyvalent cations (e.g., calcium, aluminum, and magnesium) in food. Systemic exposure to eltrombopag may be decreased when it is coadministered with a polyvalent cation-containing product. Eltrombopag should not be taken within 4 hours of any oral products containing polyvalent cations, such as aluminum salts, (like aluminum hydroxide), calcium salts, (including calcium carbonate), and magnesium salts.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.